11 out of 12 Analysts have ”Buy”ratings after this company just uplisted to NASDAQ on May 21st!!
No matter your stance on the cannabis legalization boom, it is hard to ignore the fact that many solid companies are practically exploding as the push for legalization continues around America…
And this pot stock just uplisted to the NASDAQ! The company has top tier financial results, state-of-the-art technology as well as an experienced management team. They also expect to be a leader in chocolate edibles and are interviewing advisors to help identify strategic partners.
They are focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint… providing investors with a great opportunity to potentially get excellent returns!
Net revenue has grown at a blistering pace. Compared to their Q2 2018 net revenue, their Q2 2019 net revenue increased by an eye-popping 693%!
This company’s market cap is currently sitting at approximately C$1.7 billion. Compared to their competitors such as Tilray’s $4.6 billion market cap, they have a lot of room for growth.
Check out this company that is positioned to grow significantly!
Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or
authorizing the transfer of your email address to the advertiser listed above. Zacks has no control over how
your email address is used by the advertiser or other third parties. Accordingly, Zacks disclaims all
responsibility and liability arising from the subsequent use of your email address that is made possible by
your submission of your email address above. You are receiving this email from Zacks Investment Research
because you chose to receive messages from Zacks’ partners on the Zacks web site(s). Please note that
Zacks does not produce or endorse this product, and assumes no responsibility for the use thereof.
If you do not wish to receive further email solicitations from Zacks on behalf of its partners, please click here
Zacks Investment Research
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.